Marsh (NYSE:MRSH) & Health In Tech (NASDAQ:HIT) Critical Review

Health In Tech (NASDAQ:HIT) and Marsh (NYSE:MRSH) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability.

Risk and Volatility

Health In Tech has a beta of 8.53, suggesting that its stock price is 753% more volatile than the S&P 500. Comparatively, Marsh has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.

Valuation & Earnings

This table compares Health In Tech and Marsh”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$30.72 million	1.99	$1.71 million	$0.03	35.74
Marsh	$26.98 billion	3.21	$4.16 billion	$8.43	21.22

Marsh has higher revenue and earnings than Health In Tech. Marsh is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Health In Tech and Marsh, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	0	1	2.50
Marsh	0	6	1	1	2.38

Health In Tech currently has a consensus price target of $2.50, suggesting a potential upside of 133.14%. Marsh has a consensus price target of $207.38, suggesting a potential upside of 15.94%. Given Health In Tech’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Health In Tech is more favorable than Marsh.

Insider and Institutional Ownership

88.0% of Marsh shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 0.4% of Marsh shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Health In Tech and Marsh’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Marsh	15.42%	31.60%	8.26%

Summary

Marsh beats Health In Tech on 9 of the 14 factors compared between the two stocks.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

About Marsh

Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, catastrophe and financial modeling, and related advisory services; and insurance program management services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth, and career consulting services and products; and specialized management, as well as economic and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.